期刊文献+

存活素在妊娠滋养细胞肿瘤中的表达及其与Fas/Fas-L表达的相关性研究 被引量:1

Expressions of Survivin and relationship with Fas/Fas-L expression in gestational trophoblastic tumor
下载PDF
导出
摘要 目的探讨存活素(Survivin)在妊娠滋养细胞肿瘤(GTT)中的表达及其与Fas/Fas-L表达的相关性。方法应用免疫组织化学方法检测存活素在侵蚀性葡萄胎(15例)及绒毛膜上皮癌(绒癌)(11例)中的表达,正常滋养细胞(40份)作为对照;并与Fas/Fas-L表达进行相关性分析。结果存活素在15例侵蚀性葡萄胎组有9例(60%)阳性,在11例绒癌组有8例(73%)阳性。而在40份正常滋养细胞中仅有11例(28%)阳性,存活素在GTT中的表达增高,且随着妊娠滋养细胞疾病的进展阳性率逐渐增高。正常滋养细胞组与绒癌组差异有统计学意义(P<0.05)。存活素与Fas表达在绒癌中呈负相关。结论凋亡抑制蛋白存活素表达上调可能参与了GTT的发生发展。Fas表达的下调和存活素表达的上调可能在GTT的发生发展过程中起协同作用,二者共同抑制细胞凋亡,逃避免疫清除,进而导致肿瘤的发生。 Objective To determine the expressions of Survivin and its relationship with the expression of Fas/Fas-L in gestational trophoblastic tumor (GTT).Methods Immunohistochemical assay was employed to detect Survivin expression in the tissues derived from 15 patients with invasive hydatidiform mole and 11 with choriocarcinoma,with 40 cases who had normal villi as the control group.This entailed the correlation analysis on Fas/Fas-L.Results Survivin immunoreactivity was shown in 9 of 15 cases (60%) with invasive hydatidiform mole,8 of 11 cases (72.7%)with choriocarcinoma and in 11 of 40 cases (28%) with normal villi.The expression of Survivin in GTT was heightened compared with that in the normal villi and increased progressively with the advancement of disease severity.There was a significant difference in the expression of Survivin between normal villi and choriocarcinoma group (P<0.05).The Fas was negatively correlated with Survivin expression in patients with choriocarcinoma.Conclusion The up-regulation of Survivin could have involved in the pathogenesis of GTT,and may act synergistically with the downregulation of Fas expression,which inhibit cell apoptosis and suppress immune clearance,thus leading to the tumorigenesis.
作者 平毅 赵卫红
出处 《中国药物与临床》 CAS 2013年第11期1405-1407,I0002,共4页 Chinese Remedies & Clinics
基金 山西省卫生厅科技攻关计划项目(200819)
关键词 妊娠滋养细胞肿瘤 存活素 FAS FAS-L Gestational trophoblastic neoplasms Survivin Fas Fas-L
  • 相关文献

参考文献10

  • 1琚玲丽,刘惠宁,蔡净亭,徐静.妊娠滋养细胞疾病中NF-κBp65和IκBα的表达及临床意义[J].细胞与分子免疫学杂志,2012,28(10):1084-1087. 被引量:3
  • 2Stafford L, McNally OM, Gibson P, et al. Long-term psychological morbidity, sexual functioning, and relationship outcomes in women with gestational trophoblastic disease. Int J Gynecol Can- cer,2011,21 (7) : 1256-1263.
  • 3Kunze D,Erdmann K,Froehner M,et al. Enhanced inhibition of bladder cancer cell growth by simultaneous knockdown of anti- apoptotic Bcl-xL and Survivin in combination with chemotherapy. Int J Mol Sci,2013,14(6) : 12297-12312.
  • 4Tian J,Pau F,Li J,et al. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis. Asian Pac J Cancer Prev,2012,13(3) :945-951.
  • 5Villa-Morales M, Fernandez-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets, 2012,16(1) :85-101.
  • 6平毅,卫建平,王伟,武学清.Fas及FasL在妊娠滋养细胞疾病中的表达及意义[J].中国妇幼健康研究,2009,20(3):305-308. 被引量:2
  • 7Sarti M, Pinton S, Limoni C, et al. Differential expression of testin and survivin in breast cancer subtypes. Oncol Rep,2013,30(2): 824-832.
  • 8Srivastava AK,Singh PK,Srivastava K,et al. Diagnostic role of survivin in urinary bladder cancer. Asian Pae J Cancer Prev, 2013,4( 1 ) : 81-85.
  • 9郭卫东,张惠洁,崔晓梅,李慧丽,牛德森.Survivin、HSP70和Fas在乳腺癌中的表达及其意义[J].临床肿瘤学杂志,2011,16(9):785-789. 被引量:2
  • 10Suzuki A, ho T, Kawano H,et al. Survivin initiates procaspase 3/ p21 complex formation as a result of interaction with Cdk4 to re- sist Fas-mediatedcell death. Oncogene,2000,19 (10) : 1346- 1353.

二级参考文献31

  • 1杨隽钧,向阳,万希润,李勤,何凤权,杨秀玉.妊娠滋养细胞肿瘤患者的死亡原因及相关因素分析[J].中华妇产科杂志,2006,41(6):403-407. 被引量:9
  • 2Rajashelchar G,Loganath A,Roy A C,et al.Co-expression of Fas(APO-1,CD95)/Fas ligand by BeWa anti NJC choriocarcinoma cell lines[J].Cynecol Oncol,2003,91(1):101-111.
  • 3Rajashelchar G,Loganath A,Roy A C,et al.Resistance to Fas-mediated cell death in BeWo and NJG choriocarcinoma cell lines:Implications in immune privilege[J].Cynecol Oncol,2003,91(1):89-100.
  • 4Wongweragial S, Searle R F, Bulmer J N. Decidual T lymphocyte activation in hydatidiform mole [ J ]. J Clin Pathol, 1999,52 ( 12 ) : 888-894.
  • 5Wongweragial S,Searle R F,Bulmer J N.Expression of Fas/Fas ligand by decidual leukocytes in hydatidiform mole[J].Biol Reprod,2001,64(3):784-789.
  • 6Yongcharoen S,Searle R F,Bulmer J N.Placental Fas and Fas ligand expression in normal early,term and molar pregnancy[J].Placenta,2004,25(41):321-330.
  • 7Hanefeld M,Marx N,Pfüitzner A,et al.Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein:the PIOSTAT study[J].J Am Coll Cardiol,2007,49 (3):290-297.
  • 8Ozanne EM,Loberg A,Hughes S,et al.Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome[J].Breast J,2009,15(2):155-162.
  • 9Span PN,Tjan-Heijnen VC,Manders P,et al.High survivin predicts a poor response to endocrine therapy,but a good response to chemotherapy in advanced breast cancer[J].Breast Cancer Res Treat,2006,98 (2):223-230.
  • 10Rashmi R,Kumar S,Karunagaran D,et al.Ectopic expression of HSP70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis[J].Carcinogenesis,2004,25 (2):179-187.

共引文献4

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部